Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3065

Actual shortage: 232 (8%)
Anticipated shortage: 15 (0%)
Avoided shortage: 9 (0%)
Resolved: 2809 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-02-16 206563
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-26 2024-05-31 217481
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-26 225793
APO-GLIMEPIRIDE 4MG TABLET Resolved 2017-11-28 2019-09-21 31007
APO-GLIMEPIRIDE 1MG TABLET Resolved 2017-12-12 2019-09-21 32536
APO-GLIMEPIRIDE 2MG TABLET Resolved 2018-07-11 2019-09-21 55281
APO GLYBURIDE TAB 2.5MG 2.5MG TABLET Resolved 2019-11-20 2019-12-04 99295
APO GLYBURIDE TAB 2.5MG 2.5MG TABLET Resolved 2020-09-17 2020-10-05 124350
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-11 2022-08-12 164378
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-01-12 206579
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2024-01-12 209339
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-08 2024-01-12 212949
APO-GUANFACINE XR 4MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-15 2024-01-12 213559
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2022-06-12 2022-07-28 162475
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-08-06 165317
APO-GUANFACINE XR 4MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-08-06 165322
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-12 214220
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-12 214232
APO-HALOPERIDOL TAB 10MG 10MG TABLET Actual shortage 2017-08-13 2017-10-05 18945
APO-HYDRALAZINE 25MG TABLET Resolved 2017-08-03 2017-10-10 18184

Showing 1221 to 1240 of 3065

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TADALAFIL 20MG TABLET Discontinued 2018-09-10 2019-02-13 61045
APO-TAMOX TAB 20MG 20MG TABLET Discontinued 2018-09-10 2019-09-12 61050
APO-TELMISARTAN 40MG TABLET Discontinued 2018-02-23 2018-09-15 40811
APO-TELMISARTAN 40MG TABLET Discontinued 2018-02-23 2018-09-15 40814
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40817
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40820
APO-TELMISARTAN 40MG TABLET Discontinued 2019-01-04 2019-01-04 71345
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Discontinued 2018-02-23 2018-09-15 40823
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Discontinued 2018-02-23 2018-09-15 40826
APO-TELMISARTAN/HCTZ 25MG 80MG TABLET Discontinued 2018-02-23 2018-05-07 40829
APO-TELMISARTAN/HCTZ 25MG 80MG TABLET Discontinued 2018-02-23 2018-05-07 40832
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Discontinued 2018-02-26 2018-02-26 40957
APO-TERAZOSIN 1MG TABLET Discontinued 2017-03-30 2018-02-05 4745
APO-TERAZOSIN 5MG TABLET Discontinued 2017-03-30 2018-02-05 4749
APO-TERAZOSIN 2MG TABLET Discontinued 2017-03-31 2018-02-05 4974
TIGECYCLINE 50MG POWDER FOR SOLUTION To be discontinued 2019-06-21 2019-06-21 87218
APO-TIMOP 0.5% SOLUTION Discontinued 2019-01-03 2019-01-03 70894
APO-TIMOP GEL Discontinued 2019-01-03 2019-01-03 71020
APO-TOLTERODINE 1MG TABLET Discontinued 2018-09-08 2019-01-17 60822
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2018-11-09 60825

Showing 301 to 320 of 356